(2026). Retraction: Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma. PLoS ONE, 21(3), 1. https://doi.org/10.1371/journal.pone.0344546
Chicago Style (17th ed.) Citation"Retraction: Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma." PLoS ONE 21, no. 3 (2026): 1. https://doi.org/10.1371/journal.pone.0344546.
MLA (9th ed.) Citation"Retraction: Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma." PLoS ONE, vol. 21, no. 3, 2026, p. 1, https://doi.org/10.1371/journal.pone.0344546.
